0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Role of the V2R–βarrestin–Gβγ complex in promoting G protein translocation to endosomes

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Classically, G protein-coupled receptors (GPCRs) promote signaling at the plasma membrane through activation of heterotrimeric Gαβγ proteins, followed by the recruitment of GPCR kinases and βarrestin (βarr) to initiate receptor desensitization and internalization. However, studies demonstrated that some GPCRs continue to signal from internalized compartments, with distinct cellular responses. Both βarr and Gβγ contribute to such non-canonical endosomal G protein signaling, but their specific roles and contributions remain poorly understood. Here, we demonstrate that the vasopressin V 2 receptor (V 2R)–βarr complex scaffolds Gβγ at the plasma membrane through a direct interaction with βarr, enabling its transport to endosomes. Gβγ subsequently potentiates Gα s endosomal translocation, presumably to regenerate an endosomal pool of heterotrimeric G s. This work shines light on the mechanism underlying G protein subunits translocation from the plasma membrane to the endosomes and provides a basis for understanding the role of βarr in mediating sustained G protein signaling.

          Abstract

          A V2R–βarrestin–Gβγ complex forms at the plasma membrane and translocates to endosomes. This sheds light on G protein subunit translocation and βarr’s role in sustained signaling.

          Related collections

          Most cited references72

          • Record: found
          • Abstract: found
          • Article: not found

          Crystal Structure of the β2Adrenergic Receptor-Gs protein complex

          G protein-coupled receptors (GPCRs) are responsible for the majority of cellular responses to hormones and neurotransmitters as well as the senses of sight, olfaction and taste. The paradigm of GPCR signaling is the activation of a heterotrimeric GTP binding protein (G protein) by an agonist-occupied receptor. The β2 adrenergic receptor (β2AR) activation of Gs, the stimulatory G protein for adenylyl cyclase, has long been a model system for GPCR signaling. Here we present the crystal structure of the active state ternary complex composed of agonist-occupied monomeric β2AR and nucleotide-free Gs heterotrimer. The principal interactions between the β2AR and Gs involve the amino and carboxyl terminal α-helices of Gs, with conformational changes propagating to the nucleotide-binding pocket. The largest conformational changes in the β2AR include a 14 Å outward movement at the cytoplasmic end of transmembrane segment 6 (TM6) and an alpha helical extension of the cytoplasmic end of TM5. The most surprising observation is a major displacement of the alpha helical domain of Gαs relative to the ras-like GTPase domain. This crystal structure represents the first high-resolution view of transmembrane signaling by a GPCR.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Transduction of receptor signals by beta-arrestins.

            The transmission of extracellular signals to the interior of the cell is a function of plasma membrane receptors, of which the seven transmembrane receptor family is by far the largest and most versatile. Classically, these receptors stimulate heterotrimeric G proteins, which control rates of generation of diffusible second messengers and entry of ions at the plasma membrane. Recent evidence, however, indicates another previously unappreciated strategy used by the receptors to regulate intracellular signaling pathways. They direct the recruitment, activation, and scaffolding of cytoplasmic signaling complexes via two multifunctional adaptor and transducer molecules, beta-arrestins 1 and 2. This mechanism regulates aspects of cell motility, chemotaxis, apoptosis, and likely other cellular functions through a rapidly expanding list of signaling pathways.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              The Molecular Basis of G Protein–Coupled Receptor Activation

              G protein–coupled receptors (GPCRs) mediate the majority of cellular responses to external stimuli. Upon activation by a ligand, the receptor binds to a partner heterotrimeric G protein and promotes exchange of GTP for GDP, leading to dissociation of the G protein into α and βγ subunits that mediate downstream signals. GPCRs can also activate distinct signaling pathways through arrestins. Active states of GPCRs form by small rearrangements of the ligand-binding, or orthosteric, site that are amplified into larger conformational changes. Molecular understanding of the allosteric coupling between ligand binding and G protein or arrestin interaction is emerging from structures of several GPCRs crystallized in inactive and active states, spectroscopic data, and computer simulations. The coupling is loose, rather than concerted, and agonist binding does not fully stabilize the receptor in an active conformation. Distinct intermediates whose populations are shifted by ligands of different efficacies underlie the complex pharmacology of GPCRs.
                Bookmark

                Author and article information

                Contributors
                michel.bouvier@umontreal.ca
                Journal
                Commun Biol
                Commun Biol
                Communications Biology
                Nature Publishing Group UK (London )
                2399-3642
                7 July 2024
                7 July 2024
                2024
                : 7
                : 826
                Affiliations
                [1 ]Department of Biochemistry and Molecular Medicine, University of Montreal, ( https://ror.org/0161xgx34) Montreal, QC H3T 1J4 Canada
                [2 ]GRID grid.14848.31, ISNI 0000 0001 2292 3357, Institute for Research in Immunology and Cancer, , University of Montreal, ; Montreal, QC H3T 1J4 Canada
                [3 ]GRID grid.26009.3d, ISNI 0000 0004 1936 7961, Department of Biochemistry, , Duke University School of Medicine, ; Durham, NC 27710 USA
                [4 ]Department of Medicine, Duke University Medical Center, ( https://ror.org/04bct7p84) Durham, NC 27710 USA
                [5 ]Present Address: Department of Molecular Pathobiology, New York University School of Dentistry, ( https://ror.org/0190ak572) New York, NY 10010 USA
                Author information
                http://orcid.org/0000-0002-5770-1858
                http://orcid.org/0000-0003-1638-8911
                http://orcid.org/0000-0003-4965-0883
                http://orcid.org/0000-0001-9272-4484
                http://orcid.org/0009-0000-4216-8985
                http://orcid.org/0000-0003-2034-2684
                http://orcid.org/0000-0001-9924-3253
                http://orcid.org/0000-0003-1128-0100
                Article
                6512
                10.1038/s42003-024-06512-y
                11228049
                38972875
                32cc1beb-f67c-4445-ba61-4110177e9966
                © The Author(s) 2024

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 8 June 2023
                : 27 June 2024
                Funding
                Funded by: FundRef https://doi.org/10.13039/501100000038, Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (Conseil de Recherches en Sciences Naturelles et en Génie du Canada);
                Award ID: RGPIN/05556-2019
                Award Recipient :
                Categories
                Article
                Custom metadata
                © Springer Nature Limited 2024

                cell signalling,receptor pharmacology,molecular biology,hormone receptors

                Comments

                Comment on this article